Is there a subset of breast cancer patients who may benefit more from GnRH analogs for fertility preservation compared to others?  

In the prior research and the meta-analysis conducted by Lambertini et al., use of GnRH was not associated with any group of premenopausal women doing worse from a disease standpoint. Further we now know from the Suppression of Ovarian Function with Triptorelin Trial (SOFT) that adding ovarian suppr...